HSTOQ — Histogen Share News
0.000.00%
FinancialsHighly SpeculativeMicro Cap
- $0.01m
- -$5.60m
- $3.77m
Brief: Histogen Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Histogen Hires Alfred Spada As Chief Scientific Officer
Histogen Inc reports results for the quarter ended in September - Earnings Summary
Brief: Histogen Reports Third Quarter 2022 Financial Results
Histogen Inc expected to post a loss of $1.26 a share - Earnings Preview
Histogen Inc reports results for the quarter ended in June - Earnings Summary
Brief: Histogen Reports Q2 2022 Results
Histogen Inc expected to post a loss of $1.70 a share - Earnings Preview
Brief: Histogen Files For Shelf Of Up To 5.6 Mln Shares
Brief: Histogen Gets Notice of Regaining Compliance With Nasdaq Minimum Bid Price Continued Listing Requirement
Brief: Histogen Announces 1-For-20 Reverse Stock Split
Histogen Inc reports results for the quarter ended in March - Earnings Summary
Histogen Inc expected to post a loss of 7 cents a share - Earnings Preview
Brief: Histogen Announces $4.75 Million Private Placement
Brief: Allegan Sales To Pay $3.75 Mln To Histogen
Histogen Inc reports results for the quarter ended in December - Earnings Summary
Brief: Histogen Reports Fourth Quarter And Year-End 2021 Financial Results And Provides Business Update
Histogen Inc expected to post a loss of 10 cents a share - Earnings Preview
Brief: Histogen Inc Says Pursuant To Prospectus, Selling Stockholders Are Offering On A Resale Basis An Aggregate Of 16.9 Million Shares Of Common Stock